跳至主要内容
临床试验/CTRI/2019/05/019310
CTRI/2019/05/019310已完成2 期

The efficacy of Murivenna Lepam in the management of Parikartika(fissure-in-ano): A randomized controlled trial - FAME

Dr Sreerag M V0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients diagnosed as having Fissure-in-Ano
  • 2)Patients of both sexes in between the age group of 12 and 60 years
  • 3)Patients of fissure in ano with systemic diseases like Diabetes and Hypertension which are well under control were also included in the study

排除标准

  • 1)Patients having Parikartika (Fissure-in-Ano) secondary to Ulcerative colitis, Chron’s disease, Syphilis, Tuberculosis and Ca. of rectum of anal canal.
  • 2)Patients with infectious diseases like HIV and HBsAg.
  • 3)Uncontrolled Diabetes mellitus and Hypertension

研究者

发起方
Dr Sreerag M V

相似试验